Lobular carcinoma in situ (LCIS) is a non-invasive breast condition that affects the milk-producing lobules of the breast. It is often considered a marker for an increased risk of developing breast cancer in the future. This article aims to provide a basic understanding of LCIS, its diagnosis, and its implications.
LCIS is a condition where abnormal cells are found in the lobules of the breast. Unlike invasive breast cancer, LCIS does not invade the surrounding breast tissue or spread to other parts of the body. It is usually detected incidentally during a routine mammogram or breast biopsy.
LCIS is often diagnosed through a breast biopsy, which involves removing a sample of breast tissue for examination under a microscope. The biopsy helps determine if the cells in the lobules are abnormal and if they resemble invasive cancer or not. It is important to note that LCIS does not typically cause any noticeable symptoms or breast lumps.
LCIS itself is not considered cancer, but it is considered a risk factor for developing invasive breast cancer in either breast. Women diagnosed with LCIS have an increased risk of developing breast cancer in the future, often in the same breast where LCIS was detected. However, it is important to understand that the majority of women with LCIS will never develop invasive breast cancer.
After an LCIS diagnosis, regular breast cancer screening is crucial. This typically includes annual mammograms and clinical breast exams. Some women may choose to take preventive measures, such as hormonal therapy or risk-reducing surgeries, like bilateral mastectomy. However, these decisions should be made in consultation with a healthcare professional based on individual risk factors and preferences.
In conclusion, LCIS is a non-invasive breast condition that signifies an increased risk of developing breast cancer in the future. It is typically diagnosed incidentally and does not cause noticeable symptoms. Regular breast cancer screening and consultation with a healthcare professional are important for monitoring and managing the condition. Remember, early detection is key in successfully managing breast health.
Lobular carcinoma in situ (LCIS) of the breast is a condition where abnormal cells are found in the milk-producing glands of the breast. Although it is not a form of cancer, it is considered a risk factor for developing invasive breast cancer in the future. Treatment options for LCIS aim to manage the risk and pr...
To see full information about treatment please Sign up or Log in